Wound Mgmt Tech receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sanara Medtech Inc (SMTI)
Sanara Medtech Inc stock price live, this page displays NASDAQ SMTI stock exchange data. View the SMTI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sanara Medtech Inc real time stock price chart below.
What Is the Sanara Medtech Inc Stock Price Today?
The Sanara Medtech Inc stock price today is 21.37.
What Is the Stock Symbol for Sanara Medtech Inc?
The stock symbol for Sanara Medtech Inc is ""SMTI.""
What Stock Exchange Does Sanara Medtech Inc Trade On?
Sanara Medtech Inc is listed and trades on the NASDAQ stock exchange.
Is Sanara Medtech Inc a Good Stock to Buy?
Determining whether Sanara Medtech Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SMTI quote. (ISIN: US79957L1008)
What Is the Sanara Medtech Inc Stock Price Today?
The Sanara Medtech Inc stock price today is 21.37.
What Is the Stock Symbol for Sanara Medtech Inc?
The stock symbol for Sanara Medtech Inc is ""SMTI.""
What Stock Exchange Does Sanara Medtech Inc Trade On?
Sanara Medtech Inc is listed and trades on the NASDAQ stock exchange.
Is Sanara Medtech Inc a Good Stock to Buy?
Determining whether Sanara Medtech Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SMTI quote. (ISIN: US79957L1008)
NASDAQ
Currency in USD
21.37
+1.76(+8.98%)
Real-time Data·
Fair Value
An estimate of a Sanara Medtech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
19.52
21.80
52 wk Range
19.10
38.75
SMTI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Sanara Medtech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
19.5221.80
52 wk Range
19.1038.75
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SMTI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Sanara Medtech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
50.00
Upside
+133.97%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
- Form 8K Sanara Medtech Inc For: 12 November
- Investing.com
- Wound Mgmt Tech receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 8K Sanara Medtech Inc For: 12 November
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell
Sanara Medtech Inc Company Profile
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns. It also develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement. The company has a license agreement with Rochal to develop, market, and sell antimicrobial products that include BIASURGE Advanced Surgical Solution, BIAKOS Antimicrobial Wound Gel, and BIAKOS Antimicrobial Skin and Wound Cleanser for the prevention and treatment of microbes on the human body. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
Sanara Medtech Inc Earnings Call Summary for Q2/2025
- Q2 2025 revenue up 28% YoY to $25.8M; net income of $500K, reversing previous year's loss; stock surged 8.45% premarket
- Soft tissue sales up 28% to $22.7M; bone fusion sales up 25% to $3.1M; consolidated adjusted EBITDA up 350% to $2.7M
- Exploring strategic alternatives for THP segment; plans to invest $5.5-6.5M in H2 2025; no material cash investments expected after year-end
- CEO emphasizes focus on sustainable growth; CCO highlights product impact on high-risk patient outcomes as key revenue driver
- Analysts inquired about distributor onboarding, THP strategic partnerships, and ongoing R&D innovation efforts
Last Updated: 13/08/2025, 14:00
Read Full TranscriptCompare SMTI to Peers and Sector
Metrics to compare | SMTI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSMTIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −28.4x | −0.9x | −0.6x | |
PEG Ratio | 0.09 | −0.02 | 0.00 | |
Price/Book | 28.5x | 1.9x | 2.6x | |
Price / LTM Sales | 1.7x | 3.4x | 3.3x | |
Upside (Analyst Target) | 136.9% | 30.8% | 41.3% | |
Fair Value Upside | Unlock | 28.2% | 4.9% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 50.00
(+133.97% Upside)
Earnings
Latest Release
Nov 12, 2025
EPS / Forecast
-3.40 / -0.255
Revenue / Forecast
26.33M / 25.80M
People Also Watch
FAQ
What Is the Sanara Medtech (SMTI) Premarket Price Today?
The Sanara Medtech (SMTI) premarket price is 19.71. Premarket price change units: 0.10. Premarket percentage change: 0.51%. Premarket volume: 1,190.00. Current date: 14 Nov 2025. Previous close: 19.61
What Stock Exchange Does Sanara Medtech Trade On?
Sanara Medtech is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Sanara Medtech?
The stock symbol for Sanara Medtech is "SMTI."
What Is the Sanara Medtech (SMTI) Afterhours Price Today? (Afterhours variable test: 20.20) Current Date: 14 Nov 2025
After hours price: 20.20. After hours price change (units): 0.59. Price change percentage: 3.01%
What Is the Sanara Medtech Market Cap?
As of today, Sanara Medtech market cap is 194.69M.
What Is Sanara Medtech's Earnings Per Share (TTM)?
The Sanara Medtech EPS (TTM) is -4.36.
When Is the Next Sanara Medtech Earnings Date?
Sanara Medtech will release its next earnings report on 31 Mar 2026.
From a Technical Analysis Perspective, Is SMTI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Sanara Medtech Stock Split?
Sanara Medtech has split 2 times.
How Many Employees Does Sanara Medtech Have?
Sanara Medtech has 141 employees.
What is the current trading status of Sanara Medtech (SMTI)?
As of 14 Nov 2025, Sanara Medtech (SMTI) is trading at a price of 21.37, with a previous close of 19.61. The stock has fluctuated within a day range of 19.52 to 21.80, while its 52-week range spans from 19.10 to 38.75.
What Is Sanara Medtech (SMTI) Price Target According to Analysts?
The average 12-month price target for Sanara Medtech is USD50, with a high estimate of USD54 and a low estimate of USD46. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +133.97% Upside potential.
What Is the SMTI Premarket Price?
SMTI's last pre-market stock price is 19.71. The pre-market share volume is 1,190.00, and the stock has decreased by 0.10, or 0.51%.
What Is the SMTI After Hours Price?
SMTI's last after hours stock price is 20.20, the stock has decreased by 0.59, or 3.01%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.